As reported in the results, SC concentration increased notably by COVID‐19, but since IL‐6 did not significantly increase in COVID‐19 patients, its follow‐up may not be as an effective marker as SC for assessing disease recovery. The gene discussed is IL6; the disease is COVID-19.